| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.153 | 580 | 110 | 1.665 | 672 | 184 | 0 | 568 | 1.573 | 760 |
| Total Income - EUR | 23.513 | 614 | 110 | 1.665 | 672 | 184 | 0 | 568 | 1.921 | 2.274 |
| Total Expenses - EUR | 15.778 | 3.738 | 1.645 | 1.097 | 471 | 190 | 44 | 103 | 3.257 | 4.020 |
| Gross Profit/Loss - EUR | 7.735 | -3.124 | -1.536 | 568 | 201 | -6 | -44 | 464 | -1.336 | -1.746 |
| Net Profit/Loss - EUR | 7.071 | -3.142 | -1.539 | 518 | 181 | -12 | -44 | 447 | -1.336 | -1.746 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Stadimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.640 | 2.387 | 2.347 | 2.304 | 2.259 | 2.216 | 2.167 | 2.174 | 0 | 0 |
| Current Assets | 17.389 | 15.927 | 10.378 | 10.482 | 10.458 | 10.349 | 9.938 | 10.421 | 10.873 | 9.657 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.338 | 3.379 | 3.378 | 3.299 | 3.236 | 3.143 | 3.074 | 3.089 | 3.054 | 3.031 |
| Cash | 14.051 | 12.547 | 7.000 | 7.183 | 7.222 | 7.206 | 6.864 | 7.332 | 7.819 | 6.626 |
| Shareholders Funds | 17.153 | 13.837 | 12.064 | 12.361 | 12.302 | 12.057 | 11.745 | 12.229 | 10.873 | 9.067 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.876 | 4.477 | 661 | 425 | 416 | 509 | 360 | 366 | 0 | 590 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Stadimed S.r.l.